Study of apathy in people with schizophrenia or depression
Part of Brain & nervous system clinical trials.
This study looks at “apathy,” or reduced motivation/interest, in people with schizophrenia or depression. It may help researchers understand what drives apathy and how to measure it in a clearer, more complete way.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be between 18 and 60 years old
- Have health insurance and be able to sign informed consent
- Have a diagnosis that meets research criteria for schizophrenia or depression
- Do not have a major medical condition that is not stable
- Avoid recent brain-related conditions or events like stroke or major brain surgery
- For patients: avoid benzodiazepines; for controls: avoid psychotropic medicines in the last 3 weeks
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a digital therapy to improve apathy (feeling unmotivated or “checked out”) in people age 60+ who have depression. It also uses brain imaging (MRI) and questionnaires to see whether the treatment helps brain function linked to motivation.
This trial tests a new approach using deep brain stimulation (a treatment that uses tiny electrical pulses in the brain) to help with severe apathy—a common and hard-to-treat symptom of Parkinson's disease where you lose interest and motivation. If you've tried medications without success, this study might offer another option.
This Phase 3 trial uses special brain scans (PET) to understand what brain chemical systems are involved in apathy after stroke. Your results may help researchers better understand the cause of apathy and guide future treatments.
This study tests whether music can help reduce apathy (low motivation) in people with Parkinson’s disease. It may help your mood and daily drive by targeting brain and behavior pathways tied to apathy.
This study looks at whether apathy and certain brain markers can help predict memory and thinking problems in people over 70 with bipolar disorder. If you are 70-85, have bipolar disorder, and are currently stable (no recent mood episodes), you may be able to join.
This study tests a medicine called methylphenidate (often used for ADHD) to see if it helps reduce apathy—feelings of lack of motivation or interest—in people with Parkinson's disease. If it works, it could improve your quality of life and daily functioning.
Hear when a new Apathy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.